Bookmark
Forward
QuickView for Quazepam (compound)
PubChem
| Name: | quazepam |
|---|---|
| PubChem Compound ID: | 10647691 |
| Molecular formula: | C26H23NO7 |
| Molecular weight: | 461.463 g/mol |
DrugBank
Identification
| Name: | quazepam |
|---|---|
| Name (isomeric): | DB01589 |
| Drug Type: | small molecule |
| Synonyms: |
Quazepamum [inn-latin]
|
| Brand: | Oniria, Selepam, Dormalin, Quazium, Cetrane, Doral, Prosedar |
| Category: | Benzodiazepines, Anti-anxiety Agents, GABA Modulators, Hypnotics and Sedatives |
| CAS number: | 36735-22-5 |
Pharmacology
| Indication: | Used to treat insomnia. |
|---|---|
| Pharmacology: | Quazepam is a benzodiazepine derivative. The main pharmacological action of quazepam is the enhancement of the neurotransmitter, GABA at the GABAA receptor. |
| Mechanism of Action: |
Benzodiazepines bind nonspecifically to benzodiazepine receptors, which affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA recept...
show more » |
| Absorption: | Bioavailability is 29-35% following oral administration. |
| Biotransformation: | Hepatic. |
| Half Life: | 39 hours |
| Affected organisms: | Humans and other mammals |
Interactions
| Drug interaction: |
|
|---|
Targets
Enzymes
